DNA Damage-Mediated Induction of a Chemoresistant Niche
Author(s)
Gilbert, Luke Andrew; Hemann, Michael
DownloadGilbert-2010-DNA Damage-Mediated.pdf (1.488Mb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
While numerous cell-intrinsic processes are known to play decisive roles in chemotherapeutic response, relatively little is known about the impact of the tumor microenvironment on therapeutic outcome. Here, we use a well-established mouse model of Burkitt's lymphoma to show that paracrine factors in the tumor microenvironment modulate lymphoma cell survival following the administration of genotoxic chemotherapy. Specifically, IL-6 and Timp-1 are released in the thymus in response to DNA damage, creating a “chemo-resistant niche” that promotes the survival of a minimal residual tumor burden and serves as a reservoir for eventual tumor relapse. Notably, IL-6 is released acutely from thymic endothelial cells in a p38-dependent manner following genotoxic stress, and this acute secretory response precedes the gradual induction of senescence in tumor-associated stromal cells. Thus, conventional chemotherapies can induce tumor regression while simultaneously eliciting stress responses that protect subsets of tumor cells in select anatomical locations from drug action.
Date issued
2010-10Department
Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MITJournal
Cell
Publisher
Elsevier B.V.
Citation
Gilbert, Luke A., and Michael T. Hemann. “DNA Damage-Mediated Induction of a Chemoresistant Niche.” Cell 143, no. 3 (October 2010): 355–366. © 2010 Elsevier B.V.
Version: Final published version
ISSN
00928674